Allergan Aesthetics To Launch Three New State-of-the-Art Training Centers in the U.S. Expanding Access to High Quality Aesthetics Training
Allergan Aesthetics, an AbbVie (NYSE: ABBV) company, today announced Allergan Medical Institute (AMI) will open three new ...
Allergan Aesthetics Invites Consumers to Join the Faces of Natrelle® Campaign
Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced a nationwide open casting call in search of the next Faces of Natrelle®, encouraging women who have experienced breast reconstruction and ...
Morningstar18d
Allergan Aesthetics launches new AA Signature Program at IMCAS 2025 to redefine patient-centric, multimodal treatment plans
NORTH CHICAGO, Ill., Jan. 29, 2025 /PRNewswire/ -- In response to growing demand for personalized, patient-centric aesthetic solutions1,2, Allergan Aesthetics, an AbbVie Company, is proud to ...
Morningstar9d
Allergan Aesthetics Invites Consumers to Join the Faces of Natrelle® Campaign
Talk to your doctor about other complications. At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics ...
Science-Based Medicine2d
Botulinum Toxin: A tale of medicine, beauty, and danger
When used responsibly botulinum toxin is very safe, but patients should be especially vigilant about cosmetic treatments done ...
BioSpace12d
AbbVie’s Marketing Misstep Further Erodes 2024 Aesthetics Sales
AbbVie launched a revamped version of its Allē loyalty program, which ultimately was not adopted by providers. The marketing ...
Longview News-Journal23d
Allergan Aesthetics unveils new AA Signature Program and immersive booth at IMCAS World Congress 2025
Allergan Aesthetics Medical Symposium Mastering the Lower Face and Neck On Friday January 31, 2025, Dr. Alexandre Marchac, Dr. Karim Sayed, Dr. Patricia Ogilvie and Dr. Sylwia Lipko-Godlewska will ...
AbbVie and Xilio Therapeutics Announce Collaboration and Option Agreement to Develop Novel Tumor-Activated Immunotherapies
Collaboration will combine AbbVie’s oncology expertise and Xilio’s proprietary tumor-activation technology to develop novel immunotherapies, ...
The Victoria Advocate10d
Allergan Aesthetics Invites Consumers to Join the Faces of Natrelle® Campaign
Breast implants are not considered lifetime devices. The longer people have them, the greater the chances are that they will develop complications, some of which will require more surgery. Breast ...